Pharmaceuticals and Job Lock-Out Assignment Example | Topics and Well Written Essays - 1250 words

Pharmaceuticals and Job Lock-Out - Assignment ExampleAlso, cost of health c ar is projected to rise from the current $2.1 trillion yearly to $4 trillion in the adjoining 10 years (Callahan, 2008).These escalating costs atomic number 18 significant contributors to the rising number of uninsured people. Business entities are finding it difficult to cater for their employees health benefits. The current statistics show that active 61% of employers afford to earnings for their employees indemnity as compared to a decade ago which was about 70%. Also, employers that enforce their employees the health benefits are using co-payments and deductibles as a means of reducing their expenses thus forces employees to pay more. The uninsured lot that is about 15% is at a risk of both health-wise and financially. Nevertheless, the high health cost currently threatens everyone, flat those in Medicaid and Medicare programs (Callahan, 2008).Hitherto, though there is great awareness among peopl e on the risks of rising costs, this problem has non compelled the attention of the public, media or presidents with the pressure of the uninsured (this is true irrespective of the recent opinions polls showing its rising popularity). There are quite developments of strategies to achieve universal care, but not much has been done in cost control since it is implicitly unpopular. This is the case since by controlling the costs, it means others will have to give something up and agree to something different (Callahan, 2008).Pharmaceuticals play a major role in providing medical resources for cure, discourse and prevention. Patents rights and rights to intellectual property develop obstacles to competition and manipulate pricing. There are some recent policies that settle to limit access to certain types of pharmaceuticals. One of such policy is proposed by the Obama administration. The policy restricts the range of insurance plan on the various drug classes. This proposed policy is receiving strong opposition from both drug companies and tolerant